Volume 47, Issue 12 , Pages 1468-1471, December 1998
Evidence that endothelin-1 (ET-1) inhibits insulin-stimulated glucose uptake in rat adipocytes mainly through ETa receptors☆
Abstract
The specificity of endothelin (ET) receptors involved in the inhibition of insulin-stimulated glucose uptake (ISGU) in rat adipocytes was investigated. Adipocytes were isolated from the epididymal fat pads of Sprague-Dawley rats. To determine receptor subtypes, we used three ET isopeptides, ET-1 and ET-2, both of which are nonselective agonists, and ET-3, a selective agonist for ETc receptors, to displace [125I]ET-1 binding from the fat cells. The efficiency of displacement was ET-1 > ET-2 ⪢ ET-3, indicating that the primary receptors involved belonged to the ETa subtype. At an equal concentration of 1 μmol/L, BQ-610, a selective ETa antagonist, displaced [125I]ET-1 from binding to fat cells, whereas IRL-1038, a selective ETb antagonist, did not. Using [3H]2-deoxy-d-1-glucose ([3H]2-DG) as a tracer in studies of glucose uptake, we found that equimolar BQ-610 completely reversed the inhibitory effect of ET-1 on ISGU, whereas IRL-1038 was ineffective. Northern blot analysis of adipocyte receptors showed abundant mRNA for ETa, but no ETb subtype. These results clearly demonstrate that ETa is the predominant receptor in rat adipocytes.
No full text is available. To read the body of this article, please view the PDF online.
To access this article, please choose from the options below
☆ Supported by grants from the Department of Health, Republic of China (DOH 86-HR-616 and DD01-86IX-MG-608S), the National Science Council (NSC 86-2314-B-075-63 and NSC 86-2113-M-075-01), and the Veterans General Hospital Research Foundation (VGH 86-291).
PII: S0026-0495(98)90071-3
© 1998 Published by Elsevier Inc.
Volume 47, Issue 12 , Pages 1468-1471, December 1998
